IMMUNOCORE HLDGS ADS/1 (6YG) — Working Capital to Net Assets Ratio

IMMUNOCORE HLDGS ADS/1 (6YG) has a Working Capital to Net Assets ratio of 196.8% as of December 2025. Working capital of €750.04 Million (current assets of €996.74 Million minus current liabilities of €246.70 Million) is measured against net assets of €381.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See IMMUNOCORE HLDGS ADS/1 net asset quality index to measure how much of total assets are equity-financed.